Veru Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Veru Inc.
Veru Inc is a biopharmaceutical company with a drug development program for the treatment of metabolic diseases, oncology, and acute respiratory distress syndrome (ARDS). The company is also in the late-stage development of certain drugs for the management of breast and prostate cancers. It also has a sexual health program that includes two products, ENTADFI, for the treatment of benign prostatic hyperplasia (BPH) and the FC2 Female Condom (Internal Condom). The company operates in a single segment and generates revenue from the USA which is the key revenue generating market, Brazil, and other regions.
/ 
Others were interested in
See all stocksFrequently asked questions
To buy Veru Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Veru Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Veru Inc. is VERU:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Veru Inc. has its primary listing on NASDAQ (Small cap). You can trade Veru Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Veru Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Veru Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Veru Inc..